Noble Financial Maintains Graham(GHM.US) With Buy Rating, Maintains Target Price $45
Graham (GHM) Receives a Buy From Noble Financial
Noble Financial Maintains Graham(GHM.US) With Buy Rating, Raises Target Price to $45
Graham Parry Recommends Sell Rating for GlaxoSmithKline Due to Concerns Over Arexvy Vaccine Efficacy and Safety
Noble Financial Reaffirms Their Buy Rating on Graham (GHM)
Press Release: Graham Holdings Company Reports Second Quarter Earnings
Graham Analyst Ratings
Michael Graham Reiterates Buy Rating on Amazon Following Strong Q4 Performance and Growth Prospects